ADAMTS9 and gastric cancer: Further FCM (Figure 5I, Supplementary Figure 1) assay results validated that LncRNA ADAMTS9-AS2 overexpression increased apoptosis ratio of CR-GC cells treated with high-dose cisplatin, which were reversed by Z-VAD-FMK and NSA.